Related Experiment Videos
TNF-alpha and chronic fatigue syndrome
R B Moss1, A Mercandetti, A Vojdani
1The Immune Response Corporation, Carlsbad, California 92008, USA. shotdoc@imnr.com
Journal of Clinical Immunology
|October 27, 1999
Summary
Chronic fatigue syndrome (CFS) may be linked to increased levels of tumor necrosis factor-alpha (TNF-alpha). This study found significantly higher serum TNF-alpha in CFS patients, suggesting anti-inflammatory treatments could be beneficial.
Area of Science:
- Immunology
- Pathophysiology
- Clinical Medicine
Background:
- Chronic Fatigue Syndrome (CFS) is a complex condition with unknown etiology.
- Clinical presentation suggests a potential role for inflammatory processes.
Purpose of the Study:
- To investigate the role of tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, in the pathogenesis of CFS.
- To examine serum TNF-alpha levels in patients diagnosed with CFS.
Main Methods:
- Retrospective cross-sectional study design.
- Comparison of serum TNF-alpha levels between CFS patients and non-CFS control groups.
Main Results:
- A statistically significant elevation in serum TNF-alpha was observed in patients with CFS compared to controls (P<0.0001).
- This finding indicates a potential link between elevated TNF-alpha and CFS.
Conclusions:
- The results support the hypothesis that proinflammatory mediators, specifically TNF-alpha, are involved in CFS pathogenesis.
- Further research into anti-inflammatory therapies, including TNF-alpha blockers, for CFS treatment is warranted.